Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Konstanz

20 clinical trials in Konstanz, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Konstanz at a glance
20
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

20 trials in Konstanz

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:AZD0292
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:HUMANISED IGG1 LALAPS-YTE MONOCLONAL ANTIBODY AGAINST LYSOPHOSPHATIDIC ACID RECEPTOR 1
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AGO Research GmbH
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Letrozole
  • Sponsor:Swiss GO Trial Group
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

Coronary artery disease+2

Not yet recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Novartis Pharma AG
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ZAMPILIMAB
  • Sponsor:Chiesi Farmaceutici S.p.A.

Pulmonary fibrosis

Not yet recruiting
Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ADMILPARANT
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
  • Sponsor:Boehringer Ingelheim Espana S.A.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Konstanz

What the registry says about research in the country

01 Pulmonary Research

Innovative trials focusing on pulmonary fibrosis and related conditions, including studies of new therapeutic agents for idiopathic pulmonary fibrosis and progressive lung diseases.

  • Lung function improvement studies
  • Fibrosis treatment evaluation
  • Bronchiectasis management

Research includes long-term safety assessments and evaluation of novel compounds for respiratory conditions.

02 Oncology Studies

Comprehensive research into various cancer types, with particular focus on ovarian cancer and breast cancer treatments, including innovative combination therapies.

  • Advanced breast cancer treatments
  • Hepatocellular carcinoma therapy
  • Leukemia treatment protocols

Studies evaluate maintenance therapies and novel drug combinations for improved patient outcomes.

03 Metabolic Disorders

Clinical investigations targeting liver diseases and metabolic conditions, including studies on non-alcoholic steatohepatitis and cholesterol management.

  • Liver fibrosis treatments
  • Cholesterol reduction therapies
  • Genetic marker studies

Research focuses on innovative treatments for metabolic disorders and their complications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.